Jorgen Frokiaer
Overview
Explore the profile of Jorgen Frokiaer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
232
Citations
4204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Jochumsen M, Sorensen J, Pedersen B, Nyengaard J, Krag S, Frokiaer J, et al.
Eur J Nucl Med Mol Imaging
. 2020 Aug;
48(2):532-542.
PMID: 32808078
Purpose: Tumour blood flow (TBF) is a crucial determinant of cancer growth. Recently, we validated Rubidium-82 (Rb) positron emission tomography (PET) for TBF measurement in prostate cancer (PCa) and found...
12.
Larsen A, Wiggers H, Dollerup O, Jespersen N, Hansson N, Frokiaer J, et al.
Cardiovasc Drugs Ther
. 2020 Aug;
35(3):491-503.
PMID: 32770520
Purpose: The glucose-lowering drug metformin has recently been shown to reduce myocardial oxygen consumption and increase myocardial efficiency in chronic heart failure (HF) patients without diabetes. However, it remains to...
13.
Jochumsen M, Tolbod L, Borre M, Frokiaer J, Bouchelouche K, Sorensen J
Nucl Med Mol Imaging
. 2020 May;
54(2):120-122.
PMID: 32377264
The positron emission tomography (PET) flow tracer Rubidium is a known potassium analogue. During our studies of tumor blood flow in prostate cancer, we found that approximately 10% of the...
14.
Faergeman S, Evans H, Attfield K, Desel C, Kuttikkatte S, Sommerlund M, et al.
Cell Death Dis
. 2020 May;
11(5):303.
PMID: 32358523
Mixed lineage kinase domain-like (MLKL) is the main executor of necroptosis, an inflammatory form of programmed cell death. Necroptosis is implicated in combating infections, but also in contributing to numerous...
15.
Sundelin E, Al-Suliman N, Vahl P, Vendelbo M, Munk O, Jakobsen S, et al.
Breast Cancer Res Treat
. 2020 Apr;
181(1):107-113.
PMID: 32240455
Purpose: Epidemiological studies and randomized clinical trials suggest that the antidiabetic drug, metformin, may have anti-neoplastic effects. The mechanism that mediates these beneficial effects has been suggested to involve direct...
16.
Larsen A, Jessen N, Norrelund H, Tolbod L, Harms H, Feddersen S, et al.
Eur J Heart Fail
. 2019 Dec;
22(9):1628-1637.
PMID: 31863557
Aims: The present study tested the hypothesis that metformin treatment may increase myocardial efficiency (stroke work/myocardial oxygen consumption) in insulin-resistant patients with heart failure and reduced ejection fraction (HFrEF) without...
17.
Hanifa M, Maltesen R, Rasmussen B, Buggeskov K, Ravn H, Skott M, et al.
Metabolomics
. 2019 Dec;
16(1):7.
PMID: 31858270
Background: In our metabolomics studies we have noticed that repeated NMR acquisition on the same sample can result in altered metabolite signal intensities. Aims: To investigate the reproducibility of repeated...
18.
Schelde A, Schmidt M, Madsen M, Nielsen S, Frokiaer J, Christiansen C
Clin Epidemiol
. 2019 Oct;
11:901-910.
PMID: 31576177
Background: Comorbidity is common among patients with myocardial infarction (MI). We examined whether comorbidity level modified the single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI)-based prediction of 5-year risk...
19.
Al-Mashhadi R, Tolbod L, Bloch L, Bjorklund M, Nasr Z, Al-Mashhadi Z, et al.
J Am Coll Cardiol
. 2019 Aug;
74(9):1220-1232.
PMID: 31466620
Background: Arterial fluorodeoxyglucose (FDG) positron emission tomography (PET) is considered a measure of atherosclerotic plaque macrophages and is used for quantification of disease activity in clinical trials, but the distribution...
20.
Tingskov S, Choi H, Holst M, Hu S, Li C, Wang W, et al.
Front Physiol
. 2019 Aug;
10:948.
PMID: 31447686
Arginine vasopressin (AVP) mediates water reabsorption in the kidney collecting ducts through regulation of aquaporin-2 (AQP2). Also, estrogen has been known to regulate AQP2. Consistently, we previously demonstrated that tamoxifen...